Transfection of cytokines such as interleukin-2 (Leong et al., 1997) generated in vivo immunity to the mesothelioma tumor that was relatively weak and/or subject to down-regulation so that consistent rejection of unmodified parental tumor cells was not achieved. Here, IL2 is linked to neoplasm.